Hate Grant Writing? Stand Up and Be Counted

Recently, I cofounded a small business, and my partner and I decided that we needed capital. Since neither of us had the desire or skills to write the mandatory business plan, we hired Howie, a new MBA and my son's friend, to do it for us. We gave Howie some background information and made some guesses about what things would cost and what we would earn. After getting additional background material, Howie devised a business plan that my potential investors say is just fine.Howie could not have d

Written byWalter Brown
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Recently, I cofounded a small business, and my partner and I decided that we needed capital. Since neither of us had the desire or skills to write the mandatory business plan, we hired Howie, a new MBA and my son's friend, to do it for us. We gave Howie some background information and made some guesses about what things would cost and what we would earn. After getting additional background material, Howie devised a business plan that my potential investors say is just fine.

Howie could not have developed the idea behind our drug development business nor could he run it, but he knew how to combine our idea and the financial projections involved to make a compelling story.

Guess where this is going.

Some scientists who have what it takes to do good science can't write a grant to save their pipettes, while some who nail grants ad infinitum ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform